Xxera/openscience/retractions

Record #47504

Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment

Mototsugu Oya, Shuichi Kaneko, Tsuneo Imai, Toshiaki Tsujino, Toshiyuki Sunaya, Yutaka Okayama

Journal

Cancer Chemotherapy and Pharmacology

Publisher

Original paper date

Apr 20, 2022

Original DOI

10.1007/s00280-022-04428-0

Country

Institution

Department of Urology, Keio University School of Medicine, Tokyo, Japan · Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan · National Hospital Organization, Higashi Nagoya National Hospital, Nagoya, Japan · Medical Afairs and Pharmacovigilance, Bayer Yakuhin, Ltd., 2-4-9 Umeda, Kita-ku, Osaka 530-0001, Japan · Product Development, Bayer Yakuhin, Ltd., Osaka, Japan

Open access

No

Article type

Research Article

Broad categories

(HSC) Medicine - Oncology (HSC) Medicine - Pharmacology (HSC) Medicine - Urology/Nephrology

Citation lifecycle

How this paper is being cited

Pre-retraction

6

Same day

0

Post-retraction

5

% post-retraction

45.5%

~4.3 citations/yr before retraction · ~1.7 citations/yr after

— citing papers

Who is still citing this work

Loading…